Riemann Labs Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.70 M
- Company Age 25 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.15 Cr
- Revenue Growth -98.68%
- Profit Growth -99.17%
- Ebitda -98.84%
- Net Worth -98.82%
- Total Assets -98.39%
About Riemann Labs
Riemann Labs Private Limited (RLPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 March 1999 and has a history of 25 years and 11 months. Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.70 M.
The company currently has active open charges totaling ₹6.15 Cr.
Rajesh Bhatia, Navin Bhatia, Neeraj Bhatia, and One other member serve as directors at the Company.
Company Details
-
Location
Indore, Madhya Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232MP1999PTC013404
-
Company No.
013404
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 Mar 1999
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Riemann Labs?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Bhatia
|
Director | 26-May-2018 | Current |
|
Rajesh Bhatia
|
Director | 18-Mar-1999 | Current |
|
Navin Bhatia
|
Director | 18-Mar-1999 | Current |
|
Chandan Bhatia
|
Director | 18-Mar-1999 | Current |
Financial Performance of Riemann Labs.
Riemann Labs Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.68% decrease. The company also saw a substantial fall in profitability, with a 99.17% decrease in profit. The company's net worth observed a substantial decline by a decrease of 98.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Riemann Labs?
Unlock access to Riemann Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹61.45 M
₹0
Charges Breakdown by Lending Institutions
- Others : 5.13 Cr
- Sidbi : 1.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Mar 2024 | Sidbi | ₹1.02 Cr | Open |
| 08 Oct 2021 | Others | ₹5.13 Cr | Open |
How Many Employees Work at Riemann Labs?
Unlock and access historical data on people associated with Riemann Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Riemann Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Riemann Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.